AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Lamy, A Metayer, J Thiberville, L Frebourg, T Sesboue, R
Citation: A. Lamy et al., Re: Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas, J NAT CANC, 93(1), 2001, pp. 66-67

Authors: Millon, R Muller, D Schultz, I Salvi, R Ghnassia, JP Frebourg, T Wasylyk, B Abecassis, J
Citation: R. Millon et al., Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance, ORAL ONCOL, 37(8), 2001, pp. 620-631

Authors: Auroy, S Avril, MF Chompret, A Pham, D Goldstein, AM Bianchi-Scarra, G Frebourg, T Joly, P Spatz, A Rubino, C Demenais, F Bressac-de Paillerets, B
Citation: S. Auroy et al., Sporadic multiple primary melanoma cases: CDKN2A germline mutations with afounder effect, GENE CHROM, 32(3), 2001, pp. 195-202

Authors: Amiel, J Bougeard, G Francannet, C Raclin, V Munnich, A Lyonnet, S Frebourg, T
Citation: J. Amiel et al., TP63 gene mutation in ADULT syndrome, EUR J HUM G, 9(8), 2001, pp. 642-645

Authors: Maurici, D Monti, P Campomenosi, P North, S Frebourg, T Fronza, G Hainaut, P
Citation: D. Maurici et al., Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay, ONCOGENE, 20(27), 2001, pp. 3533-3540

Authors: Campomenosi, P Monti, P Aprile, A Abbondandolo, A Frebourg, T Gold, B Crook, T Inga, A Resnick, MA Iggo, R Fronza, G
Citation: P. Campomenosi et al., p53 mutants can often transactivate promoters containing a p21 but not Baxor PIG3 responsive elements, ONCOGENE, 20(27), 2001, pp. 3573-3579

Authors: Saugier-Veber, P Drouot, N Wolf, LM Kuhn, JM Frebourg, T Lefebvre, H
Citation: P. Saugier-veber et al., Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, EUR J ENDOC, 144(4), 2001, pp. 347-351

Authors: Drouin-Garraud, V Belgrand, M Grunewald, S Seta, N Dacher, JN Henocq, A Matthijs, G Cormier-Daire, V Frebourg, T Saugier-Veber, P
Citation: V. Drouin-garraud et al., Neurological presentation of a congenital disorder of glycosylation CDG-Ia: Implications for diagnosis and genetic counseling, AM J MED G, 101(1), 2001, pp. 46-49

Authors: Saugier-Veber, P Drouot, N Lefebvre, S Charbonnier, F Vial, E Munnich, A Frebourg, T
Citation: P. Saugier-veber et al., Detection of heterozygous SMN1 deletions in SMA families using a simple fluorescent multiplex PCR method, J MED GENET, 38(4), 2001, pp. 240-243

Authors: Bougeard, G Limacher, JM Martin, C Charbonnier, F Killian, A Delattre, O Longy, M Jonveaux, P Fricker, JP Stoppa-Lyonnet, D Flaman, JM Frebourg, T
Citation: G. Bougeard et al., Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome, J MED GENET, 38(4), 2001, pp. 253-256

Authors: Limacher, JM Frebourg, T Natarajan-Ame, S Bergerat, JP
Citation: Jm. Limacher et al., Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome, INT J CANC, 96(4), 2001, pp. 238-242

Authors: Frebourg, T Ebel, A Bonaiti-Pellie, C Brugieres, L Berthet, P Bressac-De Paillerets, B Chevrier, A Chompret, A Cohen-Haguenauer, O Delattre, O Feingold, J Feunteun, J Frappaz, D Fricker, JP Gesta, P Jonveaux, P Kalifa, C Lasset, C Leheup, B Limacher, JM Longy, M Nogues, C Oppenheim, D Sommelet, D Soubrier, F Stoll, C Stoppa-Lyonnet, D Tristant, H
Citation: T. Frebourg et al., Li-Fraumeni syndrome: update, new data and guidelines for clinical management, B CANCER, 88(6), 2001, pp. 581-587

Authors: Zurutuza, L Verpillat, P Raux, G Hannequin, D Puel, M Belliard, S Michon, A Pothin, Y Camuzat, A Penet, C Martin, C Brice, A Campion, D Clerget-Darpoux, F Frebourg, T
Citation: L. Zurutuza et al., APOE promoter polymorphisms do not confer independent risk for Alzheimer'sdisease in a French population, EUR J HUM G, 8(9), 2000, pp. 713-716

Authors: Camuzat, A Verpillat, P Dubois, B Penet, C Agid, CPY Brice, A Clerget-Darpoux, F Moreaud, O Puel, M Kinter, J Kozlov, S Berger, P Sonderegger, P Raux, G Campion, D Hannequin, D Frebourg, T
Citation: A. Camuzat et al., Mutations in the neuroserpin gene are rare in familial dementia, ANN NEUROL, 47(5), 2000, pp. 688-688

Authors: Gantier, R Gilbert, D Dumanchin, C Campion, D Davoust, D Toma, F Frebourg, T
Citation: R. Gantier et al., The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta, NEUROSCI L, 283(3), 2000, pp. 217-220

Authors: Robert, V Michel, P Flaman, JM Chiron, A Martin, C Charbonnier, F Paillot, B Frebourg, T
Citation: V. Robert et al., High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis, CARCINOGENE, 21(4), 2000, pp. 563-565

Authors: Raux, G Gantier, R Thomas-Anterion, C Boulliat, J Verpillat, P Hannequin, D Brice, A Frebourg, T Campion, D
Citation: G. Raux et al., Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation, NEUROLOGY, 55(10), 2000, pp. 1577-1578

Authors: Charbonnier, F Raux, G Wang, Q Drouot, N Cordier, F Limacber, JM Saurin, JC Puisieux, A Olschwang, S Frebourg, T
Citation: F. Charbonnier et al., Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments, CANCER RES, 60(11), 2000, pp. 2760-2763

Authors: Chompret, A Brugieres, L Ronsin, M Gardes, M Dessarps-Freichey, F Abel, A Hua, D Ligot, L Dondon, MG Bressac-de Paillerets, B Frebourg, T Lemerle, J Bonaiti-Pellie, C Feunteun, J
Citation: A. Chompret et al., p53 germline mutations in childhood cancers and cancer risk for carrier individuals, BR J CANC, 82(12), 2000, pp. 1932-1937

Authors: Lopez-Perez, E Dumanchin, C Czech, C Campion, D Goud, B Pradier, L Frebourg, T Checler, F
Citation: E. Lopez-perez et al., Overexpression of Rab11 or constitutively active Rab11 does not affect sAPP alpha and A beta secretions by wild-type and Swedish mutated beta APP-expressing HEK293 cells, BIOC BIOP R, 275(3), 2000, pp. 910-915

Authors: Bonnet-Brilhault, F Laurent, C Campion, D Thibaut, F Lafargue, C Charbonnier, F Deleuze, JF Menard, JF Jay, M Petit, M Frebourg, T Mallet, J
Citation: F. Bonnet-brilhault et al., No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia, EUR J HUM G, 7(2), 1999, pp. 247-250

Authors: Dumanchin, C Czech, C Campion, D Cuif, MH Poyot, T Martin, C Charbonnier, F Goud, B Pradier, L Frebourg, T
Citation: C. Dumanchin et al., Presenilins interact with Rab11, a small GTPase involved in the regulationof vesicular transport, HUM MOL GEN, 8(7), 1999, pp. 1263-1269

Authors: Gantier, R Dumanchin, C Campion, D Loutelier, C Lange, C Gagnon, J Davoust, D Frebourg, T Toma, F
Citation: R. Gantier et al., The L392V mutation of presenilin 1 associated with autosomal dominant early-onset Alzheimer's disease alters the secondary structure of the hydrophilic loop, NEUROREPORT, 10(14), 1999, pp. 3071-3074

Authors: Ancolio, K Dumanchin, C Barelli, H Warter, JM Brice, A Campion, D Frebourg, T Checler, F
Citation: K. Ancolio et al., Unusual phenotypic alteration of beta amyloid precursor protein (beta APP)maturation by a new Val-715 -> Met beta APP-770 mutation responsible for probable early-onset Alzheimer's disease, P NAS US, 96(7), 1999, pp. 4119-4124

Authors: Pfister, C Flaman, JM Dunet, F Grise, P Frebourg, T
Citation: C. Pfister et al., p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy, J UROL, 162(1), 1999, pp. 69-73
Risultati: 1-25 | 26-28